US FDA's Hahn Promotes Provider Role In Boosting Public Confidence In COVID-19 Products

 
• By Derrick Gingery

Agency commissioner appeals to AMA audience to communicate message that FDA review decisions are based on good science.  

Antibodies immunoglobulins attacking coronavirus covid-19 influenza virus cell, 3D immune system medical illustration background. Corona virus 2019-ncov sars cell, igm. Coronavirus sars-cov-2 disease
FDA Commissioner Stephen Hahn also said that the agency could issue an emergency use authorization for a vaccine for a patient subgroup if warranted. • Source: Shutterstock

More from Vaccines

More from Pink Sheet